Healthcare companies listed on the Nigerian Exchange closed the last trading day of 2025 with a cumulative market capitalization of N466.73 billion.
This is an impressive 220.9% increase from their combined N145.4 billion in 2024, showing strong growth in value on the exchange.
Collectively, these companies accounted for 0.47% of the total Nigerian Exchange market, which, as tracked by the All-Share Index, was valued at N99.38 trillion.
The surge in value was fueled by the exceptional performance of these companies, and in 2025, four pharmaceutical firms delivered returns exceeding 100%, closing the year firmly in the green.
One major reason for this strong performance seems to be higher sales of pharmaceutical products, which helped companies that reported nine-month or full-year results post healthier profits in 2025.
Below are the largest health companies on the NGX, covering pharmaceuticals and healthcare services, based on their market capitalization on the last trading day of 2025.
Morison Industries Plc ranks sixth with a market capitalization of N5.09 billion, based on a share price of N5.15 as of the last trading day of 2025. This is up from N3.9 billion in 2024, driven by share price appreciation on the NGX.
Much of the 2025 gain came in December, when the stock jumped 59.94% month-to-date. However, first-half declines limited the full-year return to 28.43%.
Bullish sentiment was likely supported by a rebound in earnings, as the company moved from a pre-tax loss of N76.9 million to a pre-tax profit of N54.4 million. Revenue grew to N513.7 million from N287.1 million, as pharmaceutical sales surged 111.32% to N21.8 million.
In early 2026, momentum has strengthened further, with market capitalization climbing over N15 billion following a 134.37% year-to-date gain.
